Yu Ruiqi, Han Hong, Chu Shuxian, Qin Liping, Du Mengying, Ma Yanyan, Wang Yufeng, Jiang Wei, Song Yu, Zou Yongxin, Wang Molin, Liu Qiao, Jiang Baichun, Gong Yaoqin, Sun Gongping
The Key Laboratory of Experimental Teratology of the Ministry of Education, State Key Laboratory of Reproductive Medicine and Offspring Health and Department of Histology and Embryology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
The Key Laboratory of Experimental Teratology of the Ministry of Education, State Key Laboratory of Reproductive Medicine and Offspring Health and Department of Genetics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.
Cell Death Differ. 2025 Jan;32(1):149-161. doi: 10.1038/s41418-024-01359-6. Epub 2024 Aug 14.
Mesenchymal stem cells (MSCs) are multipotent stem cells that can exert immunomodulatory capacity upon stimulation with pro-inflammatory cytokines. Our previous work has identified Cullin 4B (CUL4B), a scaffold protein in the CUL4B-RING E3 ligase (CRL4B) complex, as a key regulator in the differentiation of MSCs. Here, we demonstrate the critical role of CUL4B in regulating the immunosuppressive function of MSCs. When stimulated with pro-inflammatory cytokines, MSCs lacking CUL4B display enhanced immunosuppressive capacity, which is mediated by the elevated inducible nitric oxide synthase (iNOS). TGF-β signaling can suppress iNOS by inhibiting its transcription as well as promoting its protein degradation. We show that the CRL4B complex cooperates with PRC2 complex and HDACs to repress transcription of Dlx1 and Pmepa1, two inhibitors of TGF-β signaling, leading to decreased expression and accelerated degradation of iNOS. Our study unveils the CRL4B complex as a potential therapeutic target in promoting the immunosuppressive capacity of MSCs.
间充质干细胞(MSCs)是多能干细胞,在受到促炎细胞因子刺激时可发挥免疫调节能力。我们之前的研究已确定Cullin 4B(CUL4B),即CUL4B-RING E3连接酶(CRL4B)复合物中的一种支架蛋白,是MSCs分化的关键调节因子。在此,我们证明了CUL4B在调节MSCs免疫抑制功能中的关键作用。当受到促炎细胞因子刺激时,缺乏CUL4B的MSCs表现出增强的免疫抑制能力,这是由诱导型一氧化氮合酶(iNOS)升高介导的。转化生长因子-β(TGF-β)信号传导可通过抑制iNOS转录以及促进其蛋白质降解来抑制iNOS。我们发现CRL4B复合物与多梳蛋白抑制复合物2(PRC2)和组蛋白去乙酰化酶(HDACs)协同作用,抑制TGF-β信号传导的两种抑制剂Dlx1和Pmepa1的转录,导致iNOS表达降低和降解加速。我们的研究揭示CRL4B复合物是促进MSCs免疫抑制能力的潜在治疗靶点。